To investigate more specifically whether mitochondrial oxidative stress is critical for GBM invasiveness, we assessed invasion of U3031MG/MS cells in the transwell-laminin assay, by combining Par3 silencing with MitoTEMPO treatment, a mitochondria-targeted antioxidant (Fig. 6e). This evidence concerns the gene PARD3 and glioblastoma.